STURIALE, LUISELLA
 Distribuzione geografica
Continente #
AS - Asia 1.862
NA - Nord America 1.273
EU - Europa 644
SA - Sud America 350
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 38
OC - Oceania 3
Totale 4.317
Nazione #
US - Stati Uniti d'America 1.205
SG - Singapore 750
CN - Cina 396
IT - Italia 280
BR - Brasile 275
VN - Vietnam 217
HK - Hong Kong 178
FR - Francia 126
BD - Bangladesh 84
KR - Corea 68
NL - Olanda 67
DE - Germania 41
JP - Giappone 40
FI - Finlandia 36
IN - India 32
GB - Regno Unito 31
CA - Canada 28
AR - Argentina 25
ZA - Sudafrica 20
CO - Colombia 17
ID - Indonesia 13
MX - Messico 13
EC - Ecuador 12
PH - Filippine 10
JM - Giamaica 9
PL - Polonia 8
TR - Turchia 8
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
RU - Federazione Russa 7
SA - Arabia Saudita 7
TH - Thailandia 7
VE - Venezuela 7
HN - Honduras 6
MY - Malesia 6
PE - Perù 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
PK - Pakistan 5
AT - Austria 4
DZ - Algeria 4
MA - Marocco 4
TT - Trinidad e Tobago 4
AL - Albania 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
IE - Irlanda 3
IR - Iran 3
LB - Libano 3
UA - Ucraina 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
EG - Egitto 1
ET - Etiopia 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.173
Città #
Santa Clara 448
Singapore 405
Hong Kong 175
Hefei 155
San Jose 123
Lauterbourg 84
Ashburn 79
Ho Chi Minh City 73
Beijing 71
Hanoi 68
Seoul 68
Cavallino 62
Afragola 30
Los Angeles 29
Tokyo 28
São Paulo 25
Helsinki 23
Milan 22
Dallas 21
New York 20
Rome 19
Frankfurt am Main 17
Guangzhou 17
Buffalo 13
Da Nang 13
Lappeenranta 13
Naples 13
Council Bluffs 12
Falkenstein 10
Rio de Janeiro 10
Aci Catena 8
Amsterdam 8
Brasília 8
Brooklyn 8
Catania 8
Chicago 8
Düsseldorf 8
Hải Dương 8
Johannesburg 8
Minamishinagawa 8
Santo André 8
Bangkok 7
Haiphong 7
Orem 7
Philadelphia 7
Rende 7
Bologna 6
Denver 6
Hyderabad 6
Lisle 6
Montreal 6
Phoenix 6
Portsmouth 6
Belo Horizonte 5
Bengaluru 5
Bexley 5
Campinas 5
Cape Town 5
Charlotte 5
Columbus 5
Houston 5
London 5
Porto Alegre 5
Quito 5
Ribeirão Preto 5
Seattle 5
Toronto 5
Araraquara 4
Biên Hòa 4
Boardman 4
Bắc Giang 4
Caracas 4
Cleveland 4
Dhaka 4
Dublin 4
Elk Grove Village 4
Genoa 4
Jakarta 4
Kingston 4
Las Vegas 4
Miami 4
Ninh Bình 4
Potenza 4
Tegucigalpa 4
Thái Nguyên 4
Turin 4
Winter Garden 4
Wroclaw 4
Abidjan 3
Alexandria 3
Detroit 3
Florence 3
Fortaleza 3
Guayaquil 3
Isidro Casanova 3
Istanbul 3
Jacksonville 3
Kuala Selangor 3
Lima 3
Manchester 3
Totale 2.501
Nome #
Phenotypic and genetic spectrum of ATP6V1A encephalopathy: a disorder of lysosomal homeostasis 104
Tear N-glycomics in vernal and atopic keratoconjunctivitis 98
Caratterizzazione strutturale di polisaccaridi mediante spettrometria di massa 94
MALDI-MS CEREBROSPINAL FLUID (CSF) N-GLYCAN PROFILES IN NEURODEGENERATIVE DISEASES 93
SLC37A4-CDG: Second patient 81
Advances in Purification Methods of Serum Glycoproteins for MALDI-MS Analysis of N- Glycome in Patients with Glycosylation Disorders 79
An Unexplained Congenital Disorder of Glycosylation-II in a Child with Neurohepatic Involvement, Hypercholesterolemia and Hypoceruloplasminemia. 78
The cerebrospinal fluid (CSF) N-glycome as a novel biomarker of Parkinson's disease. A mass spectrometry-based CSF n-glycosylation study of patients affected by Parkinson's disease 78
N-Glycomics of Human Erythrocytes 75
Higher frequency of TMEM199-CDG in the southern mediterranean area is associated with c.92G>C (p.Arg31Pro) mutation 75
Analisi del Glicoma del Siero di Pazienti Affetti da Disordini Congeniti della Glicosilazione (CDG) e da Galattosemia 70
HILIC-MS based glycomics in the diagnosis of Congenital Disorders of Glycosylation 69
HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases 69
Clinical, molecular and glycophenotype insights in SLC39A8-CDG 69
CSF N-Glycomics Using MALDI MS Techniques 68
Combined mass spectrometry methods for serum N-glycoprotein profiling enhance the awareness of the molecular patho-mechanism in ALG12-CDG 66
Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption 66
Secondary disorders of glycosylation in inborn errors of fructose metabolism 63
Lipopolysaccharide from Gut‐Associated Lymphoid‐Tissue‐Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A 63
Aberrant sialylation in a patient with a HNF1 alpha variant and liver adenomatosis 62
COG6-CDG: Novel variants and novel malformation 62
PROTEOMIC ANALYSIS OF HUMAN TEAR FLUIDS USING LC-MALDI MS AND MS/MS 61
CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking 59
CSF N-Glycomics Using High-Throughput UPLC-ESI Techniques in Alzheimer’s Disease 59
Messa a punto di metodi di analisi mediante MALDI TOF ad alta risoluzione sui campioni polisaccaridici IDN 5505 e IDN 5406 frazionati mediante gpc: determinazione dei pesi molecolari; analisi strutturale di due frazioni mediante metodi classici e di spett 58
SLC35A2-CDG: Novel variant and review 58
CSF N-Glycoproteomics Using MALDI MS Techniques in Neurodegenerative Diseases 55
N-acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function 54
ANALISI DEL GLICOMA DEL FLUIDO LACRIMALE IN PAZIENTI AFFETTI DA DISORDINI CONGENITI DELLA GLICOSILAZIONE (CDG) 53
Studi di stabilità (analisi e caratterizzazione) mediante spettrometria di massa di diverse formulazioni a base di lipidi e/o proteine lacrimali 51
The Complete Structure and Pro-inflammatory Activity of the Lipooligosaccharide of the Highly Epidemic and Virulent Gram-Negative Bacterium Burkholderia cenocepacia ET-12 (Strain J2315) 50
Advanced LC-MS Methods for N-Glycan Characterization 48
Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG) 47
Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis 47
ALG12-CDG: novel glycophenotype insights endorse the molecular defect 45
Biophysical approaches to solve the structures of the complex glycan shield of chloroviruses 45
Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA 44
MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG 44
DIFFERENCES IN DISEASE SEVERITY REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 42
Hyperkinetic movement disorders in congenital disorders of glycosylation 42
Sighting of unusual glycans 42
Red blood cell N-glycan profiling by MALDI-MS 42
Identificazione rapida di batteri mediante spettrometria di massa MALDI-TOF: dallo spettro del lipooligosaccaride all individuazione di batteri gram-negativi 42
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 41
Minimal Heparin/Heparan Sulfate Sequences for Binding to Fibroblast Growth Factor-1 40
Carbohidrate and Peptide Mapping di lactoferrine naturali e ricombinanti 40
Tay-Sachs CSF N-Glycan Profile by MALDI MS Reveals Incomplete Glycosylation 39
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 39
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation 38
Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides 38
Identification of N-Glycosylation in the CSF in Patients with Alzheimer's disease by MALDI Mass Spectrometry 37
Maldi mass spectrometry for the structural investigation of intact lipopolysaccharides 37
Proteomic of human tear fluids in healthy and pathological conditions 36
Glycomics of human serum: mass spectrometry investigations of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and glactosemia 35
Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype) 35
Tear Fluid N-Glycan Profiling To Investigate Biomarkers In Vernal Keratoconjunctivitis 35
HPLC ANALYSIS OF CYCLIC ADENOSINE-DIPHOSPHATE RIBOSE AND ADENOSINE-DIPHOSPHATE RIBOSE - DETERMINATION OF NAD(+) METABOLITES IN HIPPOCAMPAL MEMBRANES 35
Advances in purification methods of serum glycoproteins for MALDI_MS analysis of N-Glycome in patients with glycosylation disorders 34
Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, self-assembly, and fluorimetry of recognition by Lens culinaris lectin 34
Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation 33
Silver-Russel sindrome-like features in a patient with abnormal transferrin glycosylation 33
Analisi mediante LC-MS di emulsioni per uso oftalmico 33
Advances in purification methods of serum glycoproteins for MALDI-MS analysis of N- Glycome in CDG patients and in Galactosemia 32
Multiplexed glycoproteomic analysis of glycosylation disorders by sequential IgY immunoseparation and MALDI TOF MS 32
DIFFERENCES IN SEVERITY OF CLINICAL PHENOTYPE REFLECT DIVERSITY OF GLYCOPROTEOME IN TWO SIBS WITH CDG-Ia 32
DEFICIENCY OF SUBUNIT 6 OF THE CONSERVED OLIGOMERIC GOLGI COMPLEX (COG6-CDG): SECOND PATIENT, DIFFERENT PHENOTYPE 31
Glycoproteomics of congenital disorders of glycosylation and secondary glycosylation disorders 31
DETERMINATION OF LINKAGE POSITIONS AND SEQUENCE OF COMPLEX CARBOHYDRATES BY MALDI-TOF-TOF MASS SPECTROMETRY 31
Exopolysaccharides as bacterial defence tools: the case of Burkholderia cepacia Complex . 31
Mass spectrometry strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 30
Cerebrospinal Fluid N-Glycomics May Enable Early Diagnosis in Alzheimer Disease 30
Trattamento di Prodotti Freschi Altamente Deperibili per Garantirne Qualità, Sicurezza e Salubrità (PROFSICURI) 30
Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype 30
Full Structural Characterisation of the Lipooligosaccharide of a Burkholderia pyrrocinia Clinical Isolate 30
The Outer Membrane of the Marine Gram-Negative Bacterium Alteromonas addita is Composed of a Very Short-Chain Lipopolysaccharide with a High Negative Charge Density 30
Novel aspects of the contribution by the lipid A acyl groups to Toll-like receptor 4 activation by lipopolysaccharide 30
Analisi dei campioni di acido ialuronico coniugati con MTX 29
Thermophiles as potential source of novel endotoxin antagonists: The full structure and bioactivity of thelipo-oligosaccharide from thermomonas hydrothermalis 29
Matrix-assisted Laser Desorption/Ionization Mass Spectrometry of Polysaccharides 29
Determination of the structure of the O-antigen and the lipid A from the entomopathogenic bacterium Pseudomonas entomophila lipopolysaccharide along with its immunological properties 29
Preliminary results on proteomics of human tear fluids : Lack of bioactive peptides and defensins in disease subjects 29
Differences in severity of clinical phenotype reflect diversity of glycosylation status in two sibs with phosphomannomutase deficiency (CDG-Ia) due to V129M/R141H mutations 28
Structural relationship of the lipid A acyl groups to activation of murine toll-like receptor 4 by lipopolysaccharides from pathogenic strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa 28
COG5-CDG with a Mild Neurohepatic Presentation 28
CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder 28
Mannosidase I deficiency: An unexpected CDG-II with intellectual disability and dysmorphic features 28
Proprietà Strutturali di Polisaccaridi Prodotti dal Batterio Patogeno Opportunista Burkholderia cepacia 28
Structural elucidation of the core-lipid A backbone from the lipopolysaccharide of Acinetobacter radioresistens S13, an organic solvent tolerant Gram-negative bacterium 26
Hypoglycosylation with increate fucosylation and branching of serum transferrin N-glycans in untreated galactosemia 26
Detailed characterization of the lipid A fraction from the nonpathogen Acinetobacter radioresistens strain S13 26
Structural Analysis of the Deep Rough Lipopolysaccharide from Gram Negative Bacterium Alteromonas macleodii ATCC 27126T: The First Finding of B-Kdo in the Inner Core of Lipopolysaccharides 25
The structure of the exocellular polysaccharide from the cyanobacterium Cyanospira capsulata 25
IDENTIFICATION OF N-ACETYLGLUCOSAMINE AND 4-O-[1-CARBOXYETHYL]MANNOSE IN THE EXOPOLYSACCHARIDE FROM CYANOSPIRA-CAPSULATA 24
Mass spectrometric strategies for the N-glycosylation analysis of serum glycoproteins in patients with congenital disorders of glycosylation (CDG) and galactosemia 23
IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives 10
MAN2A2-related glycosylation defects in autism and cognitive delay 8
Proteomics of Human Tear Fluids in Healthy and Patological Conditions 8
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain protein hypersialylation 4
null 4
Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder 3
Totale 4.317
Categoria #
all - tutte 14.511
article - articoli 8.660
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.095
Totale 24.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202433 0 0 0 0 0 0 0 0 3 3 21 6
2024/20251.724 0 2 102 54 417 52 141 111 93 104 342 306
2025/20262.176 104 167 230 286 395 81 326 92 100 133 120 142
2026/2027384 118 95 171 0 0 0 0 0 0 0 0 0
Totale 4.317